Clinicopathological analysis of prognostic factors in clinical IA peripheral adenocarcinoma of the lung
- 1 April 2003
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 75 (4) , 1113-1117
- https://doi.org/10.1016/s0003-4975(02)04718-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Preoperative Chemotherapy Followed by Surgery Compared With Primary Surgery in Resectable Stage I (Except T1N0), II, and IIIa Non-Small-Cell Lung CancerJournal of Clinical Oncology, 2002
- The role of chemotherapy in early-stage (stage I and II) resectable non-small cell lung cancerSeminars in Radiation Oncology, 2000
- Prognostic factors in clinical stage I non–small cell lung cancerThe Annals of Thoracic Surgery, 1999
- Postoperative adjuvant chemotherapy with PVM (Cisplatin+Vindesine+Mitomycin C) and UFT (Uracil+Tegaful) in resected stage I–II NSCLC (non-small cell lung cancer): a randomized clinical trial1European Journal of Cardio-Thoracic Surgery, 1999
- Small adenocarcinoma of the lung. Histologic characteristics and prognosisCancer, 1995
- Cancer statistics, 1995CA: A Cancer Journal for Clinicians, 1995
- A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1994
- Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic featuresCancer, 1994
- A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung CancerNew England Journal of Medicine, 1994
- The changing pattern of lung carcinomaCancer, 1991